Seusive Continuity

Abu Dhabi DoH · JAWDA Healthy Longevity Medicine

JAWDA outcomes

Semi-annual submission preview · H2 2026 · Jul 1 – Dec 31, 2026 · 8 enrolled members

Submission readiness
7/7

indicator measures computed for this period · 5 members need review before submission

Every value traces to a named clinician and timestamp — audit-defensible for the JAWDA e-notification.LNG004 (cognition) renders as not-yet-reportable until it takes effect in H1 2027.

VO₂ max

LNG001
Improvement or optimal maintenance in cardiorespiratory fitness
Peak VO₂ max
75%3/4 met

Metabolic risk profile

LNG002
≥20% gap closure toward each individualized target — reported per marker
HbA1c
80%4/5 met
Systolic blood pressure
100%3/3 met
LDL cholesterol
50%1/2 met

Body composition

LNG003
DEXA — fat reduction with muscle gain, against the individualized target
Subcutaneous fat (percentile)
50%1/2 met
Visceral fat (percentile)
50%1/2 met
Muscle mass (percentile)
50%1/2 met

Cognition

LNG004Effective H1 2027
Memory, executive function, processing speed
Memory score

Not yet reportable (effective 2027-01-01)

Executive function score

Not yet reportable (effective 2027-01-01)

Processing speed

Not yet reportable (effective 2027-01-01)

Before you submit

Members excluded or still in progress — never silently dropped
Hana Saeed

excluded medication (statin)

Excluded
Sara Mahmoud

only 3 visit(s) in 12mo (need 4)

Excluded
Fatima Darwish

excluded condition (diabetes_mellitus_type_1)

Excluded
Mariam Bassam

pregnant

Excluded
Noura Tariq

no follow-up observation

In progress